Quarterly report pursuant to Section 13 or 15(d)

Pro Forma Combined Historical Results (Detail)

v3.8.0.1
Pro Forma Combined Historical Results (Detail)
3 Months Ended
Mar. 31, 2017
USD ($)
$ / shares
shares
Net revenues | $ $ 98,467,260
Net loss attributable to Apollo Medical Holdings, Inc. | $ $ (351,982)
Weighted average common shares outstanding:  
Basic | shares 33,601,022
Earnings per share:  
basic | $ / shares $ (0.01)
Weighted average common shares outstanding:  
diluted | shares 33,601,022
Earnings per share:  
diluted | $ / shares $ (0.01)